263 related articles for article (PubMed ID: 16115861)
1. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress.
Tapodi A; Debreceni B; Hanto K; Bognar Z; Wittmann I; Gallyas F; Varbiro G; Sumegi B
J Biol Chem; 2005 Oct; 280(42):35767-75. PubMed ID: 16115861
[TBL] [Abstract][Full Text] [Related]
2. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
3. PARP inhibition induces Akt-mediated cytoprotective effects through the formation of a mitochondria-targeted phospho-ATM-NEMO-Akt-mTOR signalosome.
Tapodi A; Bognar Z; Szabo C; Gallyas F; Sumegi B; Hocsak E
Biochem Pharmacol; 2019 Apr; 162():98-108. PubMed ID: 30296409
[TBL] [Abstract][Full Text] [Related]
4. PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol.
Szanto A; Hellebrand EE; Bognar Z; Tucsek Z; Szabo A; Gallyas F; Sumegi B; Varbiro G
Biochem Pharmacol; 2009 Apr; 77(8):1348-57. PubMed ID: 19426673
[TBL] [Abstract][Full Text] [Related]
5. Regulation of MKP-1 expression and MAPK activation by PARP-1 in oxidative stress: a new mechanism for the cytoplasmic effect of PARP-1 activation.
Racz B; Hanto K; Tapodi A; Solti I; Kalman N; Jakus P; Kovacs K; Debreceni B; Gallyas F; Sumegi B
Free Radic Biol Med; 2010 Dec; 49(12):1978-88. PubMed ID: 20920579
[TBL] [Abstract][Full Text] [Related]
6. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.
Mathews MT; Berk BC
Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):711-7. PubMed ID: 18239155
[TBL] [Abstract][Full Text] [Related]
7. PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.
Kalmar-Nagy K; Degrell P; Szabo A; Sumegi K; Wittmann I; Gallyas F; Sumegi B
PLoS One; 2013; 8(12):e81928. PubMed ID: 24312605
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of the poly(ADP-ribose) polymerase inhibitor PJ34 on mitochondrial depolarization-mediated cell death in hepatocellular carcinoma cells involves attenuation of c-Jun N-terminal kinase-2 and protein kinase B/Akt activation.
Radnai B; Antus C; Racz B; Engelmann P; Priber JK; Tucsek Z; Veres B; Turi Z; Lorand T; Sumegi B; Gallyas F
Mol Cancer; 2012 May; 11():34. PubMed ID: 22583868
[TBL] [Abstract][Full Text] [Related]
9. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.
Virág L; Szabó C
FASEB J; 2001 Jan; 15(1):99-107. PubMed ID: 11149897
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol protects mitochondria against oxidative stress through AMP-activated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADP-ribose)polymerase-LKB1 pathway.
Shin SM; Cho IJ; Kim SG
Mol Pharmacol; 2009 Oct; 76(4):884-95. PubMed ID: 19620254
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
13. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
[TBL] [Abstract][Full Text] [Related]
15. To die or to live: the dual role of poly(ADP-ribose) polymerase-1 in autophagy and necrosis under oxidative stress and DNA damage.
Huang Q; Shen HM
Autophagy; 2009 Feb; 5(2):273-6. PubMed ID: 19139632
[TBL] [Abstract][Full Text] [Related]
16. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase.
Fonfria E; Marshall IC; Benham CD; Boyfield I; Brown JD; Hill K; Hughes JP; Skaper SD; McNulty S
Br J Pharmacol; 2004 Sep; 143(1):186-92. PubMed ID: 15302683
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.
Qin WD; Wei SJ; Wang XP; Wang J; Wang WK; Liu F; Gong L; Yan F; Zhang Y; Zhang M
Biochim Biophys Acta; 2013 Jan; 1833(1):59-68. PubMed ID: 23085506
[TBL] [Abstract][Full Text] [Related]
18. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
19. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.
Li Q; Li M; Wang YL; Fauzee NJ; Yang Y; Pan J; Yang L; Lazar A
Cell Physiol Biochem; 2012; 29(3-4):361-72. PubMed ID: 22508044
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 protects neurons against apoptosis induced by oxidative stress.
Diaz-Hernandez JI; Moncada S; Bolaños JP; Almeida A
Cell Death Differ; 2007 Jun; 14(6):1211-21. PubMed ID: 17347665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
